Advocacy News

December 6, 2016

IN THIS ISSUE

BACK TO MAIN

Orthopaedic Surgeon Tom Price Nominated to Secretary of HHS

Bonefied News

House Passes 21st Century Cures Act to Improve Innovation and Research

AMA House of Delegates – Interim Meeting 2016(OQI)

Free Webinar on the Quality Payment Program (QPP)

Deadline Extended to Review CMS Data – Now December 7, 2016

What We’re Reading

Election 2016
Graphic of the Week

PAC Participation Leader Board by State

Learn More About the Advisor’s Circle

Orthopaedic PAC Establishes Futures Capitol Club

AAOS Orthopaedic PAC Online Contribution Center and Mobile

 
MORE RESOURCES

AAOS Website

AAOS Calendar

House of Representatives Legislative Activities
   
Facebook Twitter

House Passes 21st Century Cures Act to Improve Innovation and Research 

Last week, the U.S. House of Representatives overwhelmingly passed the 21st Century Cures Act by a vote of 392-26. The American Association of Orthopaedic Surgeons (AAOS) commends members of Congress for passing this bipartisan legislation to accelerate innovation, boost research, and modernize physician practices, all of which will advance patient care exponentially.

“AAOS applauds the House of Representatives for passing this bipartisan and forward-looking legislation,” stated Thomas C. Barber, MD, Chair of the AAOS Council on Advocacy. “Specifically, AAOS commends the focus on improving electronic health records and interoperability, enhancing the flow of patient information by preventing interference in information exchange, and encouraging important research and device approval efforts. These provisions will help support coordinated care and improve the quality, safety, and efficiency of health care delivery. AAOS thanks members of Congress for this important investment in our nation’s health and we look forward to Senate passage so this legislation can be enacted as soon as possible.”

“With today’s overwhelming bipartisan vote, we took a giant leap forward on the #Path2Cures,” said Energy and Commerce Committee Chairman Fred Upton (R-MI) and Rep. Diana DeGette (D-CO), co-authors of the bill. “21st Century Cures is the innovation game-changer that patients, their loved ones, and the nation’s researchers and scientists so desperately need. The White House has expressed its enthusiastic endorsement of this critical legislation. So it’s now on to the Senate, where we are just one final vote away from delivering #CuresNow.”

The legislation now goes to the Senate where it is expected to pass without amendment early this week, despite some opposition (Democratic senators Bernie Sanders, Elizabeth Warren and Jeff Merkley have said they will oppose the bill because of concerns about weakened FDA oversight and benefits to the drug industry). The White House has said it “strongly supports” the legislation’s passage.

“This bill makes desperately needed changes to bring our laws into a modern era of medicine and to keep our nation at the forefront of health care innovation, by streamlining regulation to deliver new therapies to all patients,” stated Rep. Michael C. Burgess, M.D. (R-TX), Chairman of the House Energy and Commerce Subcommittee on Commerce, Manufacturing and Trade. “I am pleased that several of my initiatives– including neurological research legislation and interoperability standards for Electronic Health Records – are part of this innovative step forward. The discretionary spending in the bill will ensure funding is subject to congressional oversight and review through the appropriations process annually. Members of Congress from both sides of the aisle have been invested in the success of this legislation. We have made patients and their families wait long enough for life-saving cures—and now I am pleased to assure that the wait is over.”